发明公开
- 专利标题： SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
- 专利标题（中）： 螺羟吲哚化合物和它们作为治疗剂的用途
-
申请号： EP09740589.8申请日： 2009-10-13
-
公开(公告)号： EP2350090A2公开(公告)日： 2011-08-03
- 发明人: CHAFEEV, Mikhail , CHOWDHURY, Sultan , FRASER, Lauren , FU, Jianmin , LANGILLE, Jonathan , LIU, Shifeng , SUN, Jianyu , SUN, Shaoyi , SVIRIDOV, Serguei , WOOD, Mark , ZENOVA, Alla , JIA, Qi , CADIEUX, Jean-Jacques , GAUTHIER, Simon, J. , DOUGLAS, Amy Frances , HSIEH, Tom , CHAKKA, Nagasree , CIKOJEVIC, Zoran
- 申请人： Xenon Pharmaceuticals Inc.
- 申请人地址： 3650 Gilmore Way Burnaby, BC V5G 4W8 CA
- 专利权人： Xenon Pharmaceuticals Inc.
- 当前专利权人： Xenon Pharmaceuticals Inc.
- 当前专利权人地址： 3650 Gilmore Way Burnaby, BC V5G 4W8 CA
- 代理机构： Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
- 优先权： US106464P 20081017
- 国际公布： WO2010045251 20100422
- 主分类号： C07D491/20
- IPC分类号： C07D491/20 ; C07D495/20 ; C07D498/20 ; C07D491/10 ; C07D513/20 ; A61K31/407 ; A61P25/00
摘要：
This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
公开/授权文献
- EP2350090B1 SPIRO-OXINDOLE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS 公开/授权日：2015-06-03
信息查询
